Sovaldi GS-7977 API PSI7977 sofosbuvir 1190307-88-0 competitive price manufacturer producer factory in China CAS NO.1190307-88-0
- FOB Price: USD: 170.00-170.00 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,T/T
- Available Specifications:
1(1-10)Gram
- Product Details
Keywords
- sofosbuvir
- 1190307-88-0
- API
Quick Details
- ProName: Sovaldi GS-7977 API PSI7977 sofosbuvi...
- CasNo: 1190307-88-0
- Molecular Formula: C22H29FN3O9P
- Appearance: White powder
- Application: 1190307-88-0
- Port: Shanghai
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99
- LimitNum: 1 Gram
Superiority
Details
Sofosbuvir is used for the treatment of chronic hepatitis C, genotypes 1, 2, 3 and 4, in combination with pegylated interferon and ribavirin, or with ribavirin alone. It is also used in HCV patients with an HIV coinfection.[8] The treatment is based on a number of clinical trials, for example the ELECTRON trial which showed that a dual interferon-free regimen of sofosbuvir plus ribavirin produced a 24-week post-treatment sustained virological response (SVR24) rate of 100% for previously untreated patients with HCV genotypes 2 or 3.[14][15]
In early 2014, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) jointly published a recommendation for the management of hepatitis C. In this recommendation, sofosbuvir and ribavirin, with or without pegylated interferon, are part of all first-line treatments for HCV genotypes 1 to 6, and are also part of some second-line treatments.